Literature DB >> 10740283

New role for epoxyeicosatrienoic acids as anti-inflammatory mediators.

W B Campbell1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10740283     DOI: 10.1016/s0165-6147(00)01472-3

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


× No keyword cloud information.
  48 in total

1.  Analysis of epoxyeicosatrienoic acids by chiral liquid chromatography/electron capture atmospheric pressure chemical ionization mass spectrometry using [13C]-analog internal standards.

Authors:  Clementina Mesaros; Seon Hwa Lee; Ian A Blair
Journal:  Rapid Commun Mass Spectrom       Date:  2010-11-30       Impact factor: 2.419

2.  Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis.

Authors:  Luca Vanella; Martina Canestraro; Craig R Lee; Jian Cao; Darryl C Zeldin; Michal L Schwartzman; Nader G Abraham
Journal:  Prostaglandins Other Lipid Mediat       Date:  2015-04-20       Impact factor: 3.072

Review 3.  Inflammatory lipid mediators in adipocyte function and obesity.

Authors:  Abishek Iyer; David P Fairlie; Johannes B Prins; Bruce D Hammock; Lindsay Brown
Journal:  Nat Rev Endocrinol       Date:  2010-02       Impact factor: 43.330

Review 4.  Significance of brain tissue oxygenation and the arachidonic acid cascade in stroke.

Authors:  Cameron Rink; Savita Khanna
Journal:  Antioxid Redox Signal       Date:  2010-12-04       Impact factor: 8.401

Review 5.  Soluble epoxide hydrolase inhibitors and heart failure.

Authors:  Hong Qiu; Ning Li; Jun-Yan Liu; Todd R Harris; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  Cardiovasc Ther       Date:  2011-04       Impact factor: 3.023

Review 6.  Antiinflammatory and neuroprotective actions of COX2 inhibitors in the injured brain.

Authors:  Kenneth I Strauss
Journal:  Brain Behav Immun       Date:  2007-11-08       Impact factor: 7.217

7.  Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

Authors:  Jeffrey J Olearczyk; Jeffrey E Quigley; Bradford C Mitchell; Tatsuo Yamamoto; In-Hae Kim; John W Newman; Ayala Luria; Bruce D Hammock; John D Imig
Journal:  Clin Sci (Lond)       Date:  2009-01       Impact factor: 6.124

8.  Biologically active ester derivatives as potent inhibitors of the soluble epoxide hydrolase.

Authors:  In-Hae Kim; Kosuke Nishi; Takeo Kasagami; Christophe Morisseau; Jun-Yan Liu; Hsing-Ju Tsai; Bruce D Hammock
Journal:  Bioorg Med Chem Lett       Date:  2012-08-02       Impact factor: 2.823

9.  Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches.

Authors:  Ning Li; Jun-Yan Liu; Valeriy Timofeyev; Hong Qiu; Sung Hee Hwang; Dipika Tuteja; Ling Lu; Jun Yang; Hideki Mochida; Reginald Low; Bruce D Hammock; Nipavan Chiamvimonvat
Journal:  J Mol Cell Cardiol       Date:  2009-08-28       Impact factor: 5.000

10.  Variation in the human soluble epoxide hydrolase gene and risk of restenosis after percutaneous coronary intervention.

Authors:  Silke Kullmann; Priska Binner; Kirsten Rackebrandt; Andreas Huge; Georg Haltern; Mark Lankisch; Reiner Füth; Eberhard von Hodenberg; Hans-Peter Bestehorn; Thomas Scheffold
Journal:  BMC Cardiovasc Disord       Date:  2009-10-08       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.